Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

QuintilesIMS
Fish and Richardson
Harvard Business School
Chinese Patent Office
McKesson
Queensland Health
Argus Health
Medtronic
Baxter
Mallinckrodt

Generated: February 20, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,977,099

« Back to Dashboard

Summary for Patent: 5,977,099
Title: Pharmaceutical composition comprising mirtazapine and one or more selective serotonin reuptake inhibitors
Abstract:The invention relates to a pharmaceutical composition comprising mirtazapine, a selective serotonin reuptake inhibitor (SSRI) and pharmaceutically acceptable auxiliaries. In particular the SSRI is selected from fluoxetine, fluvoxamine, citalopram, cericlamine, femoxetine, sertraline, paroxetine, ifoxetine, cyanodothiepin and litoxetine. The composition which can be used to treat depressant patients has less side effects than treatment of the patients with mirtazapine or the SSRI alone.
Inventor(s): Nickolson; Victor Johannes (Hermelijnendreef, NL)
Assignee: Akzo Nobel, N.V. (Arnhem, NL)
Application Number:08/876,346
Patent Claim Types:
see list of patent claims
Compound; Composition; Use;

Drugs Protected by US Patent 5,977,099

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 5,977,099

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
96201703Jun 19, 1996

International Patents Family Members for US Patent 5,977,099

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Norway 972816 ➤ Try a Free Trial
Mexico 9704579 ➤ Try a Free Trial
Japan 4925074 ➤ Try a Free Trial
Japan 2009137970 ➤ Try a Free Trial
Japan H1067663 ➤ Try a Free Trial
Israel 121076 ➤ Try a Free Trial
Indonesia 17051 ➤ Try a Free Trial
Hungary 225534 ➤ Try a Free Trial
Hungary 9701068 ➤ Try a Free Trial
Spain 2172744 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Covington
Dow
Argus Health
Colorcon
Healthtrust
Fish and Richardson
Daiichi Sankyo
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot